Status:
COMPLETED
Skin Biopsies in Chemotherapy-Induced Neuropathy
Lead Sponsor:
Erasmus Medical Center
Conditions:
Multiple Myeloma
Peripheral Neuropathy
Eligibility:
All Genders
18+ years
Brief Summary
Neuropathy is a common side effect of chemotherapeutics used for the treatment of multiple myeloma, including vincristine, thalidomide and bortezomib. The neuropathy induced by these drugs is often pr...
Eligibility Criteria
Inclusion
- Patients with multiple myeloma receiving bortezomib
Exclusion
- Patients not able to provide informed consent
- Patients with coagulation disturbances or immunocompromised patients
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00956033
Start Date
November 1 2008
End Date
February 1 2012
Last Update
December 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus MC, Centrumlocatie en Daniel den Hoed
Rotterdam, South Holland, Netherlands, 3000CA